Bluedot, a Toronto-based health startup uses AI to track diseases around the world. They combine public health and medical expertise with advanced data analytics to analyze, surveil, and contextualize the risks pose by a variety of infectious diseases. They work with governments in 12 countries and hospital networks across North America, providing information on many features of infectious diseases, including the risk of importation and the potential for a localized outbreak.
The methods of the company have accurately predicted the arise of several outbreaks, including the migration of Ebola out of West Africa in 2014. More recently, Bluedot identified the rise of the virus that would come to be known as COVID-19 nine days before the World Health Organization made its announcement about a flu-like outbreak in China.
Dr. Kamran Khan was inspired to create the company's methods after seeing the devastation of the SARS outbreak in 2003. Bluedot announced that it closed a $7 million USD round of series A funding in August of 2019, bringing its total funding to $9.5 million USD.